Autobio Diagnostics Co (SHSE:603658) EV-to-Revenue : 6.08 (As of Jun. 19, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Autobio Diagnostics Co's enterprise value is ¥27,355 Mil. Autobio Diagnostics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4,496 Mil. Therefore, Autobio Diagnostics Co's EV-to-Revenue for today is 6.08.

The historical rank and industry rank for Autobio Diagnostics Co's EV-to-Revenue or its related term are showing as below:

SHSE:603658' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.64 Med: 14.31 Max: 28.24
Current: 6.1

During the past 13 years, the highest EV-to-Revenue of Autobio Diagnostics Co was 28.24. The lowest was 5.64. And the median was 14.31.

SHSE:603658's EV-to-Revenue is ranked worse than
73.09% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.06 vs SHSE:603658: 6.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-19), Autobio Diagnostics Co's stock price is ¥47.73. Autobio Diagnostics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥7.75. Therefore, Autobio Diagnostics Co's PS Ratio for today is 6.16.

Autobio Diagnostics Co EV-to-Revenue Historical Data

The historical data trend for Autobio Diagnostics Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co EV-to-Revenue Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

15.34

21.96

8.46

7.97

7.22

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															7.99	6.82	6.18	7.22	7.26

Competitive Comparison of Autobio Diagnostics Co's EV-to-Revenue

For the Medical Devices subindustry, Autobio Diagnostics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autobio Diagnostics Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's EV-to-Revenue falls into.

Autobio Diagnostics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Autobio Diagnostics Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	27354.576	/	4496.384
	=	6.08

Autobio Diagnostics Co's current Enterprise Value is ¥27,355 Mil.
Autobio Diagnostics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4,496 Mil.

Autobio Diagnostics Co (SHSE:603658) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Autobio Diagnostics Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	47.73	/	7.748
	=	6.16

Autobio Diagnostics Co's share price for today is ¥47.73.
Autobio Diagnostics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.75.

Autobio Diagnostics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Executives

Miao Yong Jun

Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines